Skip to main content

Table 1 Clinical characteristics and outcomes of intramedullary spinal cord tumours

From: Surgical management and outcome of intramedullary spinal cord tumour

No.

Age/sex

Localisation

Tumour extension

Neurological state pre-op MMS

Resection

Histologic origin

Surgical out come on MMS

Chemo

Radio-therapy

Post-op follow-up (MON)

Last follow-up MMS

1

46/male

Cervical

C3-C7

III

STR

ASTRO/WHO III

IV

Yes

Yes

4

III

2

68/male

Dorsal

D2-D5

III

TR

ASTRO/WHO II

III

Yes

Yes

5

II

3

57/female

Cervical

C2-C6

III

TR

EPEND/WHO II

II

No

Yes

24

I

4

70/male

Dorsal

D6-D12

IV

STR

ASTRO/WHO III

IV

Yes

Yes

7

III

5

24/female

Dorsal

D1-D4

III

TR

EPEND/WHO I

II

No

Yes

18

I

6

32/male

Conus

CONUS

II

TR

MYXOPAP/WHO I

I

No

No

12

I

7

18/male

Dorsal

D3-D6

III

TR

EPEND/WHO II

II

No

Yes

36

I

8

36/male

Cervical

C2-C5

III

STR

ASTRO/WHO II

III

Yes

Yes

8

II

9

59/female

Dorsal

D7-D12

V

STR

ASTRO/WHO IV

IV

Yes

Yes

4

III

10

55/male

Cervical

C3-C7

IV

TR

EPEND/WHO I

II

No

Yes

10

I

11

62/male

Cervical

C2-C4

IV

TR

HAEMANGIO/WHO I

II

No

No

36

I

12

53/male

Dorsal

D1-D5

IV

STR

HAEMANGIOBLAST/WHO III

IV

No

No

20

III

13

28/male

Dorsal

D7-D12

II

TR

EPEND/WHO II

II

No

Yes

12

I

14

69/male

Cervical

C5-C7

IV

TR

EPEND/WHO II

II

No

Yes

30

I

15

65/male

Cervical

C4-C6

II

STR

EPEND/WHO II

II

No

Yes

15

II

16

65/female

Cervical

C3-C6

III

TR

EPEND/WHO I

II

No

Yes

24

I

  1. C cervical, D dorsal, MMS modified McCormick scale score, STR subtotal resection, TR total resection, ASTRO astrocytoma, EPEND ependymoma, MYXOPAP myxopapillary, HAEMANGIO haemangioma, HAEMANGIOBLAST haemangioblastoma, CHEMO chemotherapy, MON month